Try The Drug Club risk-free for 30 days Trial terms

Isosorbide mononitrate ER — $0 on Listed Strengths

Isosorbide mononitrate ER is $0 on listed strengths only. Other strengths are not a blanket $0.

Isosorbide mononitrate ER Pricing

Pricing typePrice
TheDrugClub$0 on listed strengths
Typical Retail$68.00

$0 on listed strengths: 120mg Tablets (max 90); 30mg Tablets (max 90); 60mg Tablets (max 90)

About Isosorbide mononitrate ER

Isosorbide mononitrate ER is a prescription medication. Ask your doctor if Isosorbide mononitrate ER is right for you.

Other strengths and forms of Isosorbide Mononitrate

Conditions Treated with Isosorbide mononitrate ER

How to Check Isosorbide mononitrate ER Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Isosorbide mononitrate ER at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Coronary Artery Disease/Angina

About Isosorbide mononitrate ER

Isosorbide mononitrate extended-release (ER) is a vital medication for many individuals managing chronic chest pain, or angina, often associated with coronary artery disease. It works to improve blood flow to the heart, helping prevent discomfort. At TheDrugClub, we believe in making essential medications like this accessible and affordable, ensuring our members can get their prescriptions without financial burden.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Isosorbide mononitrate ER is approved for (FDA label)

Isosorbide mononitrate extended-release tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Source: Read the full FDA label on DailyMed. Label effective date: July 31, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Isosorbide mononitrate ER (FDA label)

The table below shows the frequencies of the adverse events that occurred in >5% of the subjects in three placebo-controlled North American studies, in which patients in the active treatment arm received 30 mg, 60 mg, 120 mg, or 240 mg of isosorbide mononitrate extended-release tablets once daily. In parentheses, the same table shows the frequencies with which these adverse events were associated with the discontinuation of treatment. Overall, 8% of the patients who received 30 mg, 60 mg, 120 mg, or 240 mg of isosorbide mononitrate in the three placebo-controlled North American studies discontinued treatment because of adverse events. Most of these discontinued because of headache. Dizziness was rarely associated with withdrawal from these studies.

Source: FDA prescribing information (DailyMed). Set ID: d01d4f0f-5164-4ea3-b772-72b97961c6fb. SPL document ID: 57e8068b-c8e0-5eb7-e063-6394a90a3b14. Label effective date: July 31, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Isosorbide mononitrate ER (FDA label)

Isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.

Source: FDA prescribing information (DailyMed). Set ID: d01d4f0f-5164-4ea3-b772-72b97961c6fb. SPL document ID: 57e8068b-c8e0-5eb7-e063-6394a90a3b14. Label effective date: July 31, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial